Dr. Orrin Devinsky, M.D.
Neurology (Neurology Physician)
- Medicare participating
At a glance
- Medical school
- Harvard Medical School (1982)
- Years since graduation
- 44
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 30
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1982Medical school: Harvard Medical School
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Neurology Physician primary
NY license 154530 · NJ license MA51645
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- NYU Langone Hospitals New York, NY
Medical groups
- New York University (6,134 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 30
- Services billed
- 62
- Patients’ average age
- 64
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 30-39 minutes | 61 | 52 |
| Established patient office or other outpatient visit, 40-54 minutes | 12 | 12 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Escitalopram Oxalate Other prescribers in New York, NY | 18 |
| Xcopri (cenobamate) | 14 |
| Levetiracetam Er (levetiracetam) Other prescribers in New York, NY | 12 |
| Aripiprazole Other prescribers in New York, NY | 11 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 2 companies reported 18 payments worth $22,273 in total to this clinician.
| UCB SA | $13,275 |
|---|---|
| UCB, Inc. | $8,998 |
| Consulting Fee | $20,013 |
|---|---|
| Travel and Lodging | $1,879 |
| Food and Beverage | $382 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| UCB SA Dec 12, 2025 | Consulting Fee | $5,760 |
| UCB SA Aug 29, 2025 | Consulting Fee Fintepla · Neurology | $5,473 |
| UCB, Inc. Dec 4, 2025 | Consulting Fee Fintepla · Neurology | $5,120 |
| UCB, Inc. Dec 24, 2025 | Consulting Fee Fintepla · Neurology | $2,560 |
| UCB SA Sep 5, 2025 | Consulting Fee Fintepla · Neurology | $1,100 |
| UCB SA Jul 14, 2025 | Travel and Lodging Fintepla · Neurology · travel to BOSTON, MA · in-kind | $582 |
| UCB, Inc. Dec 12, 2025 | Travel and Lodging Fintepla · Neurology · travel to Dallas, TX | $508 |
| UCB SA Jul 14, 2025 | Travel and Lodging Fintepla · Neurology · travel to BOSTON, MA · in-kind | $243 |
| UCB, Inc. Dec 8, 2025 | Travel and Lodging Fintepla · Neurology · travel to Atlanta, GA · in-kind | $207 |
| UCB, Inc. Nov 15, 2025 | Travel and Lodging Fintepla · Neurology · travel to Dallas, TX · in-kind | $147 |
All 13 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| UCB, Inc. Dec 24, 2025 | Consulting Fee Fintepla · Neurology | $2,560 |
| UCB SA Dec 12, 2025 | Consulting Fee | $5,760 |
| UCB, Inc. Dec 12, 2025 | Travel and Lodging Fintepla · Neurology · travel to Dallas, TX | $508 |
| UCB, Inc. Dec 12, 2025 | Travel and Lodging Fintepla · Neurology · travel to Dallas, TX | $72.43 |
| UCB, Inc. Dec 12, 2025 | Travel and Lodging Fintepla · Neurology · travel to Dallas, TX | $70.54 |
| UCB, Inc. Dec 12, 2025 | Travel and Lodging Fintepla · Neurology · travel to Dallas, TX | $48.67 |
| UCB, Inc. Dec 8, 2025 | Travel and Lodging Fintepla · Neurology · travel to Atlanta, GA · in-kind | $207 |
| UCB, Inc. Dec 4, 2025 | Consulting Fee Fintepla · Neurology | $5,120 |
| UCB, Inc. Nov 15, 2025 | Travel and Lodging Fintepla · Neurology · travel to Dallas, TX · in-kind | $147 |
| UCB SA Sep 5, 2025 | Consulting Fee Fintepla · Neurology | $1,100 |
| UCB SA Aug 29, 2025 | Consulting Fee Fintepla · Neurology | $5,473 |
| UCB SA Jul 14, 2025 | Travel and Lodging Fintepla · Neurology · travel to BOSTON, MA · in-kind | $582 |
| UCB SA Jul 14, 2025 | Travel and Lodging Fintepla · Neurology · travel to BOSTON, MA · in-kind | $243 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $12,564 in research payments for these studies, mostly to the institutions running them.
- A Long-term Safety Study to Assess the Potential for Chronic Liver Injury in Participants Treated With Epidiolex (Cannabidiol) Oral Solution
Jazz Pharmaceuticals Inc.
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.